Edwards Lifesciences Corp. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
937
1,439
1,225
1,271
1,338
957
Total Accounts Receivable
328
325
372
415
462
537
Inventories
309
297
340
397
555
607
Other Current Assets
152
234
112
158
178
186
Total Current Assets
1,726
2,295
2,048
2,240
2,532
2,287
Net Property, Plant & Equipment
422
443
483
580
680
868
Total Investments and Advances
22
241
380
532
567
506
Long-Term Note Receivable
7
6
-
-
-
-
Intangible Assets
443
399
834
831
1,595
1,455
Other Assets
35
49
132
123
109
34
Total Assets
2,725
3,524
4,056
4,510
5,696
5,324
ST Debt & Current Portion LT Debt
-
-
-
-
598
Accounts Payable
48
58
64
97
117
Income Tax Payable
14
17
15
6
98
Other Current Liabilities
283
359
398
430
591
Total Current Liabilities
346
434
476
533
1,403
Long-Term Debt
593
598
597
822
438
Provision for Risks & Charges
169
244
238
280
165
Deferred Taxes
70
92
181
204
214
Other Liabilities
58
56
242
256
734
Total Liabilities
1,166
1,333
1,553
1,891
2,740
Common Equity (Total)
1,559
2,191
2,503
2,619
2,956
Total Shareholders' Equity
1,559
2,191
2,503
2,619
2,956
Total Equity
1,559
2,191
2,503
2,619
2,956
Liabilities & Shareholders' Equity
2,725
3,524
4,056
4,510
5,696

About Edwards Lifesciences

View Profile
Address
One Edwards Way
Irvine California 92614
United States
Employees -
Website http://www.edwards.com
Updated 07/08/2019
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care.